Targeted liposomal formulation, especially for anticancer therapy, comprising palmitoyl-D-glucuronide, matrix phospholipid(s) and active agent(s), e.g. taxol

摘要

A composition (A) comprises palmitoyl-D-glucuronide (I) at a concentration of 0.1-20 (preferably 5-15, especially 8-12) mol. %, a matrix phospholipid (or phospholipid mixture) (II) and at least one active agent (III) An Independent claim is included for the preparation of (A).